Merck & Co’s CEO Kenneth Frazier has said the pharma industry must take on the challenge of its poor public perception. In an interview with Yahoo Finance, Frazier defended the industry’s ...

Merck & Co’s CEO Kenneth Frazier has warned that the drugs and vaccines in the pipeline to combat COVID-19 may not be enough to swiftly end the pandemic. Speaking to CNBC, Frazier said that the ...

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey Sonnenfeld and co-author Steven Tian.

As the nation kicks off Black History Month, a look into the industry shows there is a significant lack of Black leaders.

The continued soaring success of Keytruda speaks to the triumphant legacy of Merck’s former CEO, the legendary Ken Frazier, who delivered countless blockbusters during his tenure at the top from ...

The continued soaring success of Keytruda speaks to the triumphant legacy of Merck’s former CEO, the legendary Ken Frazier, who delivered countless blockbusters during his tenure at the top from which ...

Mukherjee, the Pulitzer prize-winning oncologist who has also written treatises on genetic and cellular research, will serve as Manas’ CEO ... Merck’s former chairman and chief, Ken Frazier ...

"As a former CEO in the biopharma ... discovery model", said Ken Frazier, chairman, health assurance initiatives, General Catalyst, and former chairman and CEO of Merck. "Manas AI has the ...

Ken Frazier became Merck's CEO in 2011, coming to the job by way of two decades at the pharma giant and, prior to that, a career in law. Frazier has led Merck during a strikingly succesful ...